Holen Sie sich die Stockscreener-App
9.82
4.66%
-0.48
Vorhandelsmarkt:
9.57
-0.25
-2.55%
Replimune Group Inc Aktie (REPL) Neueste Nachrichten
Replimune Group (REPL) Price Target Increased by 10.52% to 12.82 - Nasdaq
Replimune Stock Presents a Complex Investment Narrative - AD HOC NEWS
Saturn V Capital Management LP Takes $1.20 Million Position in Replimune Group, Inc. $REPL - MarketBeat
Replimune Group CEO Sushil Patel Sells 10,000 Shares - TradingView
CEO Patel Sells 10,000 ($111.3K) Of Replimune Group Inc [REPL] - TradingView
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Investors - The National Law Review
Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by Replimune Group, Inc. - The National Law Review
Will Replimune Group Inc. stock reach all time highs in 2025Oil Prices & Risk Managed Investment Strategies - BỘ NỘI VỤ
How Replimune Group Inc. stock trades during market volatility2025 Geopolitical Influence & Short-Term High Return Ideas - BỘ NỘI VỤ
Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma DrugHagens Berman (PR Newswire) - Aktiellt
What Is Driving Replimune Stock’s 98% Surge Today? - MSN
Can One97 Communications Limited Deliver Consistent Free Cash FlowsVolume Spike Alerts & Swing Trade Smarter With Data Insights - earlytimes.in
Replimune Group Inc. stock volume spike explainedWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
How Replimune Group Inc. stock reacts to global recession fearsMarket Trend Review & Smart Investment Allocation Insights - newser.com
Replimune Group (NASDAQ:REPL) Insider Sells $47,392.80 in Stock - MarketBeat
Will Replimune Group Inc. stock deliver shareholder valueQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com
Using AI based signals to follow Replimune Group Inc.Bond Market & Long Hold Capital Preservation Tips - newser.com
Trend analysis for Replimune Group Inc. this weekWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com
Replimune Group Executives Sell Shares for Tax Obligations - TradingView
[Form 4] Replimune Group, Inc. Insider Trading Activity - Stock Titan
Why Replimune Group Inc. stock is a must watch in 2025July 2025 Levels & Weekly High Momentum Picks - newser.com
Smart tools for monitoring Replimune Group Inc.’s price actionWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Replimune Group Inc. (REPL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Replimune Group Inc. stock benefit from AI adoption2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
How to use Fibonacci retracement on Replimune Group Inc.2025 Top Gainers & Risk Managed Trade Strategies - newser.com
Will Replimune Group Inc. stock deliver consistent dividendsEarnings Beat & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for Replimune Group Inc.Weekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Replimune Group (REPL) Stock Analysis Report | Financials & Insights - Benzinga
How Replimune Group Inc. stock compares to growth peersTrade Entry Report & Safe Entry Trade Signal Reports - newser.com
171,527 Shares in Replimune Group, Inc. $REPL Purchased by Candriam S.C.A. - MarketBeat
Replimune Group, Inc. (REPL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Replimune Group, Inc. (REPL) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
What hedge fund activity signals for Replimune Group Inc. stockWeekly Investment Recap & Community Verified Trade Alerts - newser.com
Replimune’s Long-Term Safety Study: A Potential Game-Changer in Oncolytic Immunotherapy - MSN
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):